350 million patients worldwide suffer from 7,000 rare diseases, yet only 300 of these diseases have approved treatments. This gap, impacting 95% of rare disease patients, represents a huge unmet medical need. Developing drugs for rare diseases poses a range of clinical, regulatory and commercial challenges. The small number of patients are difficult to identify […]
Read MoreHow to Expedite FDA Approvals of Orphan Drugs
0 comments.
Click here to read/write comments.
Topics:
PK/PD Modeling & Simulation